Obesity trials in South Korea

4 of 36 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• No phaseEnrolling by invitation
  WEgovy Real World Assessment of Weight Loss in Korea

  Where

  Busan, Daegu, Daejeon, Goyang-si, Gwangmyeong-si, Gyeonggi-do, Seongnam-si, Seongnam-si, Gyeonggi-do, Seoul, Suwon, Uijeongbu-si, Uijeongbu-si, Gyeonggi-do, Yangsan, Yongin-si

  Age

  19 years and over

  People

  500

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07280221
• No phaseEnrolling by invitation
  Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study

  Where

  Seoul

  Age

  19 years and over

  People

  800,000

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07673822
• No phaseEnrolling by invitation
  A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in Korea

  Where

  Busan, Chungcheongnam-do, Daejeon, Goyang-si, Gyeonggi-do, Seoul, Yangsan

  Age

  19 years and over

  People

  840

  Run by

  Novo Nordisk A/S

  See details and how to joinNCT07018544
• No phaseTaking people
  Nutriomics and Artificial Intelligence Nutrition Obesity Cohort

  Where

  Seoul

  Age

  19 years and over

  People

  650

  Run by

  Yonsei University

  See details and how to joinNCT05494138